Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhengyuan capsule for postoperative cancer-related fatigue in lung cancer
ChiCTR1900022712Phase 4Not yet recruiting
- Sponsor
- Shanghai Chest Hospital
- Start
- May 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Zhengyuan Capsule in cancer-related fatigue (CRF) (2 arms), sponsored by Shanghai Chest Hospital. Primary endpoint: Cancer Fatigue Scale score. Planned start May 2019; status: not yet recruiting.
02
Drugs
Zhengyuan Capsule
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on ChiCTR1900022712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022712.